Design Therapeutics, Inc. (DSGN) stock
DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.84−0.08 (-0.81%)
Close on Nov 17, 2026Market cap $615.80MP/E –Yield –
Design Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Design Therapeutics's price to book ratio was 3.3× on Nov 11, 2026, against 2.7× a year earlier. Over the last 5 years it ranged from 0.4× to 4.7×, with a median of 1.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.3× | +0.7 |
| 2025 | Dec 31, 2025 | 2.7× | +1.3 |
| 2024 | Dec 31, 2024 | 1.4× | +0.9 |
| 2023 | Dec 29, 2023 | 0.5× | −1.2 |
| 2022 | Dec 30, 2022 | 1.7× | −1.3 |
| 2021 | Dec 31, 2021 | 3.0× | – |
See a number that looks wrong?